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Doing Away With Dogma:
Increasing Afterload To Reduce
Mitral Regurgitation*
Thomas Wisenbaugh, MD, FACC
Tulsa, Oklahoma
As heart failure due to coronary and other nonvalvular heart
disease becomes more prevalent in the urbanized world,
functional mitral regurgitation will become a problem of
increasing importance (1). Functional mitral regurgitation,
which decreases effort tolerance and worsens prognosis in
cardiomyopathy (2,3), is present in most patients referred
for cardiac transplantation (4). It is therefore appropriate to
direct efforts toward understanding and treating functional
mitral regurgitation in cardiomyopathy.
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In this and a recent issue of the Journal of the American
College of Cardiology, the cardiac ultrasound team from
Massachusetts General Hospital (MGH) is challenging
traditional concepts about mitral valve function in dilated
cardiomyopathy. In severely dilated, poorly contracting
ventricles, the mitral valve sometimes appears on ultrasound
to be barely moving from a “tented” configuration some-
where between its normal fully closed position and normal
fully open position. We have always assumed this to reflect
a low flow state, and there were data in the literature to
support this intuitive notion. However, in the August issue
of the Journal of the American College of Cardiology (5), these
investigators showed that mitral leaflet excursion was re-
duced despite normal transmitral flow in patients who had
both incomplete mitral leaflet closure and severely dilated
ventricles, but was nearly normal despite reduced flow in
patients with less severely dilated ventricles. They concluded
that it is not low flow that accounts for reduced diastolic
excursion of the mitral leaflets in dilated cardiomyopathy,
but rather reduced chordal “slack,” that is, leaflet tethering
(5).
Tethering is a result of, or interacts with, several other
nonleaflet parameters to cause functional mitral regurgita-
tion. These parameters include transmitral systolic pressure
and the sizes, geometries and contraction patterns of the left
ventricle and mitral annulus. Depression of contractility has
been presumed to be the initiating factor. Secondary dila-
tion of the left ventricular chamber and to a lesser extent the
mitral annulus (8) then cause apical and lateral displacement
of the papillary muscles which, in turn, alters the location
and degree of coaptation of the mitral leaflet edges (7,8).
Experimentally increasing left ventricular size and transmi-
tral systolic pressure with angiotensin increased regurgita-
tion (9). Nitroprusside infusion, which reduced ventricular
volume, reduced mitral regurgitation without changing
transmitral systolic pressure (10). Despite its vasoconstrictor
effect, norepinephrine did not increase regurgitation because
it reduced regurgitant orifice size, presumably because of a
positive effect on contractility of either the left ventricle or
mitral annulus or both (9).
With so many variables simultaneously affecting mitral
regurgitation, it has been difficult to be certain which is the
most fundamental one. In this issue of the Journal of the
American College of Cardiology (11), the MGH team has
used the Doppler proximal flow convergence technique, at
which they are expert, to study the time-course of functional
mitral regurgitation throughout the cardiac cycle in patients
with cardiomyopathy. These investigators confirmed their
previous finding of a midsystolic decrease in regurgitant
orifice area that mirrored increases in systolic transmitral
pressure, a pattern that seems to be unique to functional and
ischemic mitral regurgitation. Because systolic decreases in
mitral annular area did not correlate as well with dynamic
regurgitant orifice area, and because there was also a
midsystolic decrease in regurgitant orifice area in four
patients with rigid mitral annular rings, they concluded that
systolic transmitral pressure—and not ventricular or annular
contractility—was of fundamental importance in mitral
valve closure. They also state that “decreased left ventricular
pressure with vasodilator therapy could potentially exacer-
bate regurgitation” and, conversely, that “increased left
ventricular pressure with increased afterload could . . . re-
duce mitral regurgitation.”
I consider their data interesting but their conclusions
faulty for two reasons. The first and most obvious reason is
that regurgitant orifice area is only one of two variables that
determine regurgitant flow. The second determinant is
transmitral systolic pressure: the higher the left ventricular
systolic pressure, the higher the regurgitant flow for any
given orifice area and left atrial pressure. This helps explain
why an earlier study of patients with functional mitral
regurgitation due to cardiomyopathy showed that 80% of
regurgitant flow occurs during midsystole even though
mitral regurgitant orifice area decreased by 20% during the
ejection phase of systole, and only 20% of total regurgitation
occurred during the preejection and postejection phases
(12). Thus, systolic pressure forces regurgitation through
the mitral orifice at a time when its size is decreasing. This
distinction is important because it is the amount of regur-
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gitant flow and not orifice size that determines left atrial
pressure and symptoms.
The data of Hung and coworkers (11) suggest a second
flaw in their eagerness to do away with dogma: they found
that the rate of change of transmitral pressure had an even
greater effect on regurgitant orifice area than pressure itself.
The rate of change of transmitral pressure, or dP/dt, is a
measure of contractility. Thus, even though they have
concluded otherwise, this finding suggests that contractility
is the most important determinant of systolic mitral valve
function. This is corroborated by the findings of others (13).
Increasing contractility shortens the preejection phase of
systole, and this is the period of the cardiac cycle when the
mitral valve is still closing and when most of the decrease in
regurgitant orifice size occurs. This is illustrated nicely in
Figures 3 and 5 of Hung et al., which seem to show very
little change in orifice size during the ejection phase of
systole.
So what should we make of their suggestion that increas-
ing left ventricular pressure and afterload might be used to
reduce functional mitral regurgitation? The answer to this
question has two facets because left ventricular pressure can
be manipulated in two ways: 1) peripheral resistance, and 2)
contractility. There is already evidence that currently used
vasodilator therapies for heart failure reduce functional
mitral regurgitation. Short-term treatment with diuretic
agents and vasodilating drugs reduced total stroke volume
but increased forward stroke volume in 15 patients with
cardiomyopathy, indicating that load reduction reduces
functional mitral regurgitation (14). Two additional studies
have shown afterload reduction with an angiotensin-
converting enzyme inhibitor to be beneficial in reducing
functional mitral regurgitation (15,16). More recently, Kiz-
ilbash and coworkers (17) found that load reduction with
nitroprusside unexpectedly increased mitral regurgitation in
approximately a fourth of their patients with mitral regur-
gitation. Hung et al. (11) cite this as evidence to support
their conclusions. However, mitral regurgitation was re-
duced by nitroprusside in all nine of their patients with
dilated cardiomyopathy (17). Thus, the weight of available
evidence supports the traditional concept that reducing left
ventricular pressure by reducing peripheral resistance re-
duces functional mitral regurgitation in cardiomyopathy.
An increase in left ventricular pressure by increasing
contractility can be achieved with short-term infusion of
dobutamine, which reduces left ventricular diastolic volume
and significantly reduces mitral regurgitant fraction (18).
Conversely, with long-term beta-blockade using metoprolol
in cardiomyopathy, there was an increase in ejection frac-
tion, a decrease in the grade of mitral regurgitation and an
increase in systolic blood pressure (19). Thus, long-term
treatments that we now know to remodel (angiotensin-
converting enzyme inhibitors) and rest (beta-blockers) the
myocardium both reduce functional mitral regurgitation
while having opposite effects on left ventricular (and prob-
ably transmitral) pressure. All these interventions probably
reduce functional mitral regurgitation by the same mecha-
nism, namely, by partially reversing the abnormalities in
ventricular contractility and geometry that caused it, and
allowing earlier and more complete coaptation of the mitral
leaflet edges. That “tethering distances were not statistically
different throughout systole” in the present study may be
due to an inability of echo to measure small (20) but
hemodynamically important differences.
In summary, increasing left ventricular and transmitral
systolic pressure can indeed be accompanied by a reduction
in functional mitral regurgitation through a reduction in
regurgitant orifice size. However, these increases in pressure
should be effected only through treatments that restore left
ventricular size and contractility, as these are the fundamen-
tal determinants of normal mitral and pump function. Thus,
the MGH group has challenged our thinking about mitral
valve function in cardiomyopathy, but the data supplied in
the present article should not alter the sound concept that
afterload reduction reduces the burden of functional mitral
regurgitation.
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